Peijia Medical (HKG:9996) said it expects an up to 17% rise in its revenue during 2025, according to a Hong Kong bourse filing Friday.
The firm expects 700 million yuan to 720 million yuan in sales for the year, 14% to 17% higher than the 615.5 million yuan booked in 2024.